Hemoglobin observations newborn screening panel

OtherAlso known as: Hb observations NBS pnl DBSN/A

Measures hemoglobin types and levels in newborn blood to detect blood disorders.

Normal Range
Consult your provider
N/A
Abnormal Levels
Consult your provider
Specimen Type
Blood

Why This Biomarker Matters

Early detection of hemoglobinopathies like sickle cell disease enables prompt treatment, preventing life-threatening complications and improving long-term outcomes for affected infants.

Overview

This newborn screening panel measures hemoglobin types and levels from a blood spot collected from heel pricks. It detects sickle cell disease, thalassemia, and other hemoglobinopathies that affect oxygen-carrying capacity. Early detection allows immediate treatment to prevent serious complications like pain crises, organ damage, and stroke. This screening is performed on all newborns in most countries and is critical for infant health outcomes.

Technical Information (LOINC Codes)

Standardized laboratory codes for this biomarker

64116-7Primary
Hemoglobin observations newborn screening panel